Pandemics and ivermectin safety

US deaths more than 1918 pandemic

Link to Wefwafwa’s channel
https://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7ow

Link to todays featured video

To donate to Wefwafwa’s work
patreon:https://www.patreon.com/awmedicalvideos

https://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.html

H1N1 virus with genes of avian origin

United States, first identified in military in spring 1918

One-third of the world’s population became infected

Global deaths, at least 50 million

US deaths, 675,000

(CDC, 2021, 666,440)

(JH, 2021, 681,199)

https://coronavirus.jhu.edu/map.html

(population, x 3 today)

Pandemic subsides, but (H1N1) continues to circulate seasonally for 38 years

https://www.cdc.gov/flu/pandemic-resources/1918-commemoration/milestone-infographic.htm

Mortality in 1918 / 1919

High in people younger than 5 years old

20-40 years old, and 65 years and older

No vaccine, no antibiotics

UK in 1918

https://www.historic-uk.com/HistoryUK/HistoryofBritain/The-Spanish-Flu-pandemic-of-1918/

Deaths, 228,000

(2021, 135,621 to 158,664)

Global infection fatality rate, 10% to 20%

Mr Biden

Extra 500 million Pfizer doses for poorer countries

The Food and Drug Administration

https://www.washingtonpost.com/health/2021/09/22/pfizer-booster-shot-fda-authorizes/

Authorized a Pfizer booster, 65 and older

People 18 through 64, at high risk of severe illness

frequent institutional or occupational exposure

Six months

Issuing emergency clearance

FDA commissioner Janet Woodcock

health care workers, teachers and day care staff, grocery workers, homeless shelters or prisons

Centers for Disease Control and Prevention still must make precise recommendations

Key goal of boosters, prevention of serious disease, not prevention of mild infection

? Pfizer booster for people who have been vaccinated with the Moderna or Johnson & Johnson

Fewer side effects after third dose of mRNA vaccines compared with the second dose

https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-09-22/07-COVID-Talbot-508.pdf

COVID-19 Vaccine Safety Technical (VaST) Work Group
Assessment of 3rd dose safety data

H. Keipp Talbot, MD MPH (VaST Chair) Robert H. Hopkins, Jr., MD (NVAC Chair)

Israel

3rd doses ,~2.8 M

≥12 years

Most to persons ≥60 years

Rates of reported systemic, local, neurologic, allergic, and other reactions were substantially lower after dose 3 than after dose 1 or 2

1,328 non serious

19 serious adverse events, (7 possibly associated with vaccination)

https://www.who-umc.org/vigibase/vigibase/

http://www.vigiaccess.org

Correction

https://www.hindustantimes.com/cities/lucknow-news/yogi-adityanath-launches-covid-19-medical-kits-for-covid-19-symptomatic-children-101623747649057.html

State government, 50 lakh medical kits through village surveillance committees

Source